Social Support Counseling Intervention for Kidney Transplant Candidates
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- Hennepin Healthcare Research Institute
- Study ID
- NCT06147076
- Status
- Recruiting
Conditions
- Kidney Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Social Support Network Counseling Intervention — BEHAVIORALSocial support counseling intervention for kidney transplant candidates along with their social support networks.
Study Details
Virtual Coaching for Potential Kidney Transplant Patients
Key Dates
- Start date
- Aug 20, 2024
- Status verified
- Dec 2024
- Primary completion
- May 31, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 86 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- No Intervention: Usual Pre-Transplant Counseling InterventionParticipants in control arm will undergo usual pre-transplant counseling as per the standard of care.
- Experimental: Social Support Network Counseling InterventionParticipants in the intervention arm will undergo an additional pretransplant counseling session along with members of their social support networks after their initial transplant evaluation and counseling.
Primary Outcome Measure
Correct Answers on Knowledge of Kidney Transplant Options Assessment [ Time Frame: one month ]
Central Contacts
- Allyson Hart, MD612-873-6998
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hennepin Healthcare | Minneapolis | Minnesota | 55415 | - |
Find similar trials in Minneapolis, MN
By research site
Related Studies
- Adipose-derived MSC to Treat Rejection in Kidney Transplant RecipientsPHASE1 · Recruiting · Mayo Clinic · Rochester, Minnesota
- Assessment of Biomarker-Guided CNI Substitution In Kidney TransplantationPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Birmingham, Alabama
- Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney TransplantationPHASE3 · Recruiting · Alexion Pharmaceuticals, Inc. · Phoenix, Arizona
- Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister DonorPHASE1/PHASE2 · Recruiting · Jeffrey Veale, MD · Los Angeles, California